Abstract

Prion diseases are a group of neurodegenerative diseases, which can progress rapidly. Previous data have demonstrated that prion protein (PrP) stimulates activation of plasminogen (Plg) by tissue plasminogen activator (tPA). In this study, using spectroscopic method, we aimed to determine whether PrP’s role in activating Plg is influenced by metal binding. We also investigated the region in PrP involved in binding to tPA and Plg, and whether PrP in fibrillar form behaves the same way as PrP unbound to any metal ion i.e., apo-PrP. We investigated the effect of recombinant mouse PrP (residues 23-231) refolded with nickel, manganese, copper, and a variant devoid of any metal ions, on tPA-catalyzed Plg activation. Using mutant PrP (H95A, H110A), we also investigated whether histidine residues outside the octarepeat region in PrP, which is known to bind tPA and Plg, are also involved in their binding. We demonstrated that apo-PrP is most effective at stimulating Plg. PrP refolded with nickle or manganese behave similar to apo-PrP, and PrP refolded with copper is least effective. The mutant form of PrP did not stimulate Plg activation to the same degree as apo-PrP indicating that the histidine residues outside the octarepeat region are also involved in binding to tPA and Plg. Similarly, the fibrillar form of PrP was ineffective at stimulating Plg activation. Our data suggest that upon loss of copper specifically, a structural rearrangement of PrP occurs that exposes binding sites to Plg and tPA, enhancing the stimulation of Plg activation.

Highlights

  • The Plg activation system, which consist of Plg, tissue plasminogen activator (tPA) and urokinase Plasminogen Activator, belong to the family of ‘serine proteinases’ which hydrolyze peptide bonds in proteins

  • Surface bound Plg is cleaved once at ­Arg561-Val562 to produce a trypsin-like serine protease called plasmin, either by tPA (Km=5.9 nM on human umbilical vein endothelial cells (12.7- fold greater efficiency than fluid phase Plg (Hajjar et al, 1986)), or by urokinase Plasminogen Activator (uPA) bound to its receptor (~22-fold acceleration compared to in solution (Ellis et al, 1989))

  • The kinetics of the activation of Glu-Plg and Lys-Plg by two-chain tPA were studied in the absence or presence of prion protein (PrP). This was compared to stimulation of tPA-catalyzed Plg activation by soluble fibrin fragment, Desafib-X (DFX)

Read more

Summary

Introduction

The Plg activation system, which consist of Plg, tPA and urokinase Plasminogen Activator (uPA), belong to the family of ‘serine proteinases’ which hydrolyze peptide bonds in proteins. They are synthesized as single chain precursors. Non-enzymatic cofactors like fibrinogen, can act to provide a specific template for the Plg activation system. Surface bound Plg is cleaved once at ­Arg561-Val562 to produce a trypsin-like serine protease called plasmin, either by tPA (Km=5.9 nM on human umbilical vein endothelial cells (12.7- fold greater efficiency than fluid phase Plg (Hajjar et al, 1986)), or by uPA bound to its receptor (~22-fold acceleration compared to in solution (Ellis et al, 1989)). Plasmin cleaves fibrinogen to fibrin, which have been shown to stimulate Plg activation further, leading to large amounts of plasmin being generated (Ellis et al, 1989)

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call